Artículos por temáticas

Effect of muscle selection for botulinum neurotoxin treatment on spasticity in patients with post-stroke elbow flexor muscle over-activity: an observational prospective study

Şengül İ, Aşkın A, Tosun A.

Somatosens Mot Res. 2021 Oct 10:1-8. doi: 10.1080/08990220.2021.1986383. Online ahead of print.

Functional assessment of stretch hyperreflexia in children with cerebral palsy using treadmill perturbations

Flux E, van der Krogt MM, Harlaar J, Buizer AI, Sloot LH.

J Neuroeng Rehabil. 2021 Oct 18;18(1):151. doi: 10.1186/s12984-021-00940-1.

Next move in movement disorders (NEMO): developing a computer-aided classification tool for hyperkinetic movement disorders

van der Stouwe AMM, Tuitert I, Giotis I, Calon J, Gannamani R, Dalenberg JR, van der Veen S, Klamer MR, Telea AC, Tijssen MAJ.

BMJ Open. 2021 Oct 11;11(10):e055068. doi: 10.1136/bmjopen-2021-055068.

The Assessment of Upper-limb Spasticity Based on a Multi-layer Process Using a Portable Measurement System

Wang C, Peng L, Hou ZG, Zhang P.

IEEE Trans Neural Syst Rehabil Eng. 2021 Oct 21;PP. doi: 10.1109/TNSRE.2021.3121780. Online ahead of print.

Disentangling acceleration-, velocity-, and duration-dependency of the short- and medium-latency stretch reflexes in the ankle plantarflexors

van 't Veld RC, van Asseldonk EHF, van der Kooij H, Schouten AC.

J Neurophysiol. 2021 Oct 1;126(4):1015-1029. doi: 10.1152/jn.00704.2020. Epub 2021 Aug 18.

Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations

Erku D, Shrestha S, Scuffham P.

Value Health. 2021 Oct;24(10):1520-1530. doi: 10.1016/j.jval.2021.04.1276. Epub 2021 Jul 17.

Convergent validity and test-retest reliability of multimodal ultrasound and related clinical measures in people with chronic stroke

Miller T, Ying MTC, Chung RCK, Pang MYC.

Arch Phys Med Rehabil. 2021 Oct 22:S0003-9993(21)01496-9. doi: 10.1016/j.apmr.2021.09.015. Online ahead of print.

Current advances and novel research on minimal invasive techniques for musculoskeletal disorders

Romero-Morales C, Bravo-Aguilar M, Abuín-Porras V, Almazán-Polo J, Calvo-Lobo C, Martínez-Jiménez EM, López-López D, Navarro-Flores E.

Dis Mon. 2021 Oct;67(10):101210. doi: 10.1016/j.disamonth.2021.101210. Epub 2021 Jun 4.

Decreased spasticity of Baishaoluoshi Decoction through the BDNF/TrKB-KCC2 pathway on poststroke spasticity rats

Xie L, Xie Y, Mao G, Cao S, Fang R, Zhou S, Jiang J, Yao T, Fan J, Liu D, Wu D, Ge J.

Neuroreport. 2021 Oct 6;32(14):1183-1191. doi: 10.1097/WNR.0000000000001709.

Gait speed and spasticity are independently associated with estimated failure load in the distal tibia after stroke: an HR-pQCT study

Miller T, Qin L, Hung VWY, Ying MTC, Tsang CSL, Ouyang H, Chung RCK, Pang MYC.

Osteoporos Int. 2021 Oct 12. doi: 10.1007/s00198-021-06191-z. Online ahead of print.

Hip Displacement in MECP2 Disorders: Prevalence and Risk Factors

Kanashvili B, Rogers KJ, Shrader MW, Miller F, Dabney KW, Howard JJ.

J Pediatr Orthop. 2021 Oct 1;41(9):e800-e803. doi: 10.1097/BPO.0000000000001898.

[Sevoflurane sedation protocol in children with cerebral palsy undergoing botulinum toxin-A injections]

León-Valenzuela A, Román Malo C, González López M, Sánchez Palacios J, Sánchez Tarifa P, Del Pino Algarrada R.

Rehabilitacion (Madr). 2021 Oct-Dec;55(4):266-272. doi: 10.1016/j.rh.2020.09.005. Epub 2021 Jan 16.

PredictMed: A Machine Learning Model for Identifying Risk Factors of Neuromuscular Hip Dysplasia: A Multicenter Descriptive Study

Bertoncelli CM, Altamura P, Bertoncelli D, Rampal V, Vieira ER, Solla F.

Neuropediatrics. 2021 Oct;52(5):343-350. doi: 10.1055/s-0040-1721703. Epub 2020 Dec 22.

Using both electromyography and movement disorder assessment improved the classification of children with dyskinetic cerebral palsy

Lorentzen J, Born AP, Svane C, Forman C, Laursen B, Reynberg Langkilde A, Uldall P, Hoei-Hansen CE.

Acta Paediatr. 2021 Oct 16. doi: 10.1111/apa.16152. Online ahead of print.

European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A

Biering-Sørensen B, Stevenson VL, Bensmail D, Grabljevec K, Moreno MM, Pucks-Faes E, Wissel J, Zampolini M.

J Rehabil Med. 2021 Oct 5. doi: 10.2340/16501977-2877. Online ahead of print.